The following Structured Product Label (SPL) was submitted to the FDA by Topiderm, Inc. for the product Rfa Bpo Acne Treatment (NDC 51326-176). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient, purpose, uses, warnings, otc - when using, otc - keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Keep away from eyes, lips, and mouth. If irritation develops, discontinue use and consult a doctor. Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, consult a doctor. May bleach fabrics.
Benzoyl Peroxide, USP 2.5%
Anti-acne
Topical acne medication.
For external use only.
When using this product avoid unnecessary sun exposure and use a sunscreen.
Keep out of reach of children.
If swallowed, seek professional assistance or contact a Poison Control Center immediately.
Once daily apply a thin layer to clean, dry skin focusing on the areas prone to acne. Let sit for 3-5 minutes, gradually increasing to 15 minutes. After using, cleanse and moisturize. Can be used as an overnight lotion for experienced users. Avoid the eye area.
Bisabolol, Carbomer, Purified Water, Sodium Hyaluronate, Sodium Hydroxymethylglycinate, Sodium Lauroyl Sarcosinate, Stearic Acid.
RFA
SKINCARE
BPO 2.5%
acne treatment
Net 2oz. (57g)
Principal Display Panel (57 g Bottle Box)
* Please review the disclaimer below.
